Pharvaris is advancing deucrictibant, an oral bradykinin B2-receptor antagonist, in two late-stage trials. Read my analysis ...

Imagine a future where artificial intelligence quietly shoulders the drudgery of software development: refactoring tangled ...

The application requires a £319 visa fee along with a healthcare surcharge. If an application is rejected, the visa fee is ...

Lyell Immunopharma's LYL314 CAR-T therapy shows durable responses in advanced LBCL patients. Learn about trials and upcoming ...

Fueling nightmares that AI may soon decide legal battles, a Georgia court of appeals judge, Jeff Watkins, explained why a ...

Skeena Resources Limited (TSX: SKE, NYSE: SKE) ('Skeena Gold & Silver”, 'Skeena” or the 'Company”) reports that it has filed ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Amid the extreme volatility in today’s markets, quant investors are leveraging artificial intelligence (AI) to enhance decision-making at the margins, rather than fully replacing traditional ...

In the battle over President Trump’s spending priorities, Republicans say they’re running the table, leaving Democratic ...

It has been noticeable for several years now — decades even — but our city has a significant and growing population of ...

Jewish philanthropy in America has been driven by the religious imperative known as “tikkun olam”—that is, to repair the ...